Quest Diagnostics
425 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2013 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 157 increasing their positions, 153 reducing their positions, and 39 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
42% more call options, than puts
Call options by funds: $58.8M | Put options by funds: $41.3M
23% more capital invested
Capital invested by funds: $9.1B → $11.2B (+$2.11B)
13% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 39
1.89% more ownership
Funds ownership: 95.02% → 96.91% (+1.9%)
3% more repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 153
0% more funds holding
Funds holding: 423 → 425 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$123M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$115M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$79.2M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$58.7M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$229M |
| 2 |
Goldman Sachs
New York
|
-$188M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$96.9M |
| 4 |
RI
Relational Investors
San Diego,
California
|
-$94.9M |
| 5 |
GTP
Global Thematic Partners
New York
|
-$75M |
DGX Hedge Fund Activity: Q3 2013 in Review
425 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2013, worth a combined $11.2B — up 23% from $9.1B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new DGX positions and 39 closed out — a net gain of 5 holders — while 157 added to existing stakes and 153 trimmed.
The largest buyer was American Century Companies, adding an estimated $123M. The largest seller was Capital World Investors, cutting an estimated $229M.
- 425 institutional investors held Quest Diagnostics (DGX) as of Q3 2013, up from 423 in Q2 2013.
- Funds reported $11.2B of Quest Diagnostics stock for Q3 2013, up 23% quarter-over-quarter.
- 44 funds opened new Quest Diagnostics positions in Q3 2013 and 39 closed out, a net change of +5 holders.
- The largest Quest Diagnostics buyer in Q3 2013 was American Century Companies, an estimated $123M added.
- The largest Quest Diagnostics seller in Q3 2013 was Capital World Investors, an estimated $229M sold.
Based on aggregated 13F filings for Q3 2013.